Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |